Tyche Wealth Partners LLC Buys New Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Tyche Wealth Partners LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,895 shares of the healthcare conglomerate’s stock, valued at approximately $2,577,000.

Several other large investors also recently bought and sold shares of the stock. Ascension Capital Advisors Inc. purchased a new position in UnitedHealth Group in the third quarter valued at about $216,000. Bellecapital International Ltd. increased its stake in shares of UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after purchasing an additional 193 shares in the last quarter. Great Valley Advisor Group Inc. increased its stake in shares of UnitedHealth Group by 5.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after purchasing an additional 1,884 shares in the last quarter. Rise Advisors LLC increased its stake in shares of UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after purchasing an additional 163 shares in the last quarter. Finally, Gradient Investments LLC increased its stake in shares of UnitedHealth Group by 6.3% during the 4th quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock worth $44,370,000 after purchasing an additional 5,023 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on UNH shares. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Royal Bank of Canada restated an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Bank of America restated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $573.80.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 5.3 %

UnitedHealth Group stock traded up $23.51 during midday trading on Tuesday, hitting $469.14. 11,815,185 shares of the stock were exchanged, compared to its average volume of 4,407,902. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The firm has a market cap of $432.51 billion, a P/E ratio of 19.66, a P/E/G ratio of 1.20 and a beta of 0.54. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The company has a 50 day moving average price of $491.15 and a two-hundred day moving average price of $515.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.54 by $0.37. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.26 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.60%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.